Change in Body Mass Index and Attributable Risk of New-Onset Hypertension Among Obese Living Kidney Donors
Overview
Authors
Affiliations
Objective: To examine whether body mass index (BMI) changes modify the association between kidney donation and incident hypertension.
Background: Obesity increases hypertension risk in both general and living kidney donor (LKD) populations. Donation-attributable risk in the context of obesity, and whether weight change modifies that risk, is unknown.
Methods: Nested case-control study among 1558 adult LKDs (1976-2020) with obesity (median follow-up: 3.6 years; interquartile range: 2.0-9.4) and 3783 adults with obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) and Atherosclerosis Risk in Communities (ARIC) studies (9.2 y; interquartile range: 5.3-15.8). Hypertension incidence was compared by donor status using conditional logistic regression, with BMI change investigated for effect modification.
Results: Overall, LKDs and nondonors had similar hypertension incidence [incidence rate ratio (IRR): 1.16, 95% confidence interval (95% CI): 0.94-1.43, P =0.16], even after adjusting for BMI change (IRR: 1.25, 95% CI: 0.99-1.58, P =0.05). Although LKDs and nondonors who lost >5% BMI had comparable hypertension incidence (IRR: 0.78, 95% CI: 0.46-1.34, P =0.36), there was a significant interaction between donor and >5% BMI gain (multiplicative interaction IRR: 1.62, 95% CI: 1.15-2.29, P =0.006; relative excess risk due to interaction: 0.90, 95% CI: 0.24-1.56, P =0.007), such that LKDs who gained weight had higher hypertension incidence than similar nondonors (IRR: 1.83, 95% CI: 1.32-2.53, P <0.001).
Conclusions: Overall, LKDs and nondonors with obesity had similar hypertension incidence. Weight stability and loss were associated with similar hypertension incidence by donor status. However, LKDs who gained >5% saw increased hypertension incidence versus similar nondonors, providing support for counseling potential LKDs with obesity on weight management postdonation.
Evaluating Risk in Kidney Living Donors.
Ortiz F, Marson L, Thomas R, Kousios A, Rista E, Lefaucheur C Transpl Int. 2025; 38:14024.
PMID: 40078501 PMC: 11896807. DOI: 10.3389/ti.2025.14024.
Weight Loss Intentionality and Frailty are Associated with Pre-Kidney Transplant Outcomes.
Ghildayal N, Hong J, Liu Y, Li Y, Cockey S, Ali N Clin J Am Soc Nephrol. 2024; .
PMID: 39621583 PMC: 11835156. DOI: 10.2215/CJN.0000000604.
Velez-Bermudez M, Rishel Brakey H, Myaskovsky L, Unruh M, Singh P, Pandhi N Clin Transplant. 2024; 38(10):e15476.
PMID: 39422104 PMC: 11852387. DOI: 10.1111/ctr.15476.
Killian A, Reed R, McLeod M, Maclennan P, Kumar V, Pittman S PLoS One. 2022; 17(11):e0276882.
PMID: 36399462 PMC: 9674148. DOI: 10.1371/journal.pone.0276882.